Javits Neuroscience Investigator Award Extension Request (Type 4 Clinical Trial Optional)
Requesting extension for the Javits Neuroscience Investigator Award (Type 4 Clinical Trial Optional) to provide up to seven years of support to exceptional investigators in two phases.
This grant is no longer accepting proposals
National Institutes of Health has archived this opportunity.
Funder: National Institutes of Health
Due Dates: September 15, 2022 (earliest) | December 9, 2025 (final deadline) | Applications due 60 days before end of initial phase
Funding Amounts: Up to 3 years of additional support; budget as indicated in current Notice of Award; no stated cap.
Summary: Provides a second phase of funding for current NINDS Javits Neuroscience Investigator Award (R37) recipients demonstrating exceptional performance.
Key Information: Only current NINDS Javits R37 awardees are eligible to apply for this extension.
Description
This opportunity supports currently funded recipients of the NINDS Javits Neuroscience Investigator Award (R37) seeking a second phase of funding. The extension provides up to three additional years of support for investigators with a record of exceptional scientific achievement and productivity. The goal is to allow awardees to continue their impactful neuroscience research without interruption, building on the progress of their initial four-year project period. Applications may include or exclude clinical trials.
